Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Oxybate therapy is currently the standard of care for the treatment of excessive daytime sleepiness (EDS) and cataplexy in patients living with narcolepsy. However, other approved oxybate products are immediate release formulations requiring two nightly doses - one dose at bedtime and the second dose 2.5-4 hours later, in the middle of the night.
LUMRYZ TM (sodium oxybate) extended release for oral suspension, applies our proprietary drug delivery technology to allow for a single bedtime dose, eliminating the need to have a forced awakening during the middle of the night and giving patients the chance for an uninterrupted night’s sleep. An extended-release medication sounds like a simple innovation, but it has been lacking for more than 20 years prior to our May 1, 2023 approval, and we believe this can be transformative for people with narcolepsy. For more information, please visit www.avadel.com or check out narcolespydisrupts.com.
FDA-approved LUMRYZ (sodium oxybate) is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy. The FDA found LUMRYZ to be clinically superior to currently marketed twice-nightly oxybate products and granted LUMRYZ seven years of Orphan Drug Exclusivity for adults on May 1, 2023, and again for pediatric patients 7 years and older on October 16, 2024. In both instances, FDA found that LUMRYZ makes a major contribution to patient care over currently available, twice-nightly oxybate products by providing a once-nightly dosing regimen that avoids nocturnal awakening to take a second dose.
At Avadel, patients are the reason we exist, and our employees are our greatest competitive advantage – our “secret sauce.” The way we work is as important as the results we achieve. Our employees work together as ONE team and live our Values, which is what makes working at Avadel so special and why we will win for patients. Our ONE Team approach fosters a culture based on being relentless for patients, having confidence with humility , being courageous , taking insights to impact, and togetherness . In everything we do, we live the Avadel Values so we can be our best for our patients, our community and each other.
We need individuals who will dive in, roll up their sleeves, and join us to continue the LUMRYZ launch and our mission to serve the narcolepsy community.
If you are looking for an opportunity to develop a world class insight generation capability at a small, fast-paced, fun, high growth, emerging pharma company, then let’s talk. We are looking for someone with a passion for market research, who is equally comfortable “in the weeds” of data as putting together compelling stories to bring insights to life. S/he will help to shape and drive brand strategy, develop annual insight plans, and provide thought partnership to Commercial Leadership. S/he will be responsible for leading market research and insight generation in support of LUMRYZ, and will become the internal expert on, and voice of, our patients and providers. This role will play a critical role on Avadel’s Strategic Market Insight & Commercial Analytics (SMICA) team.
Manage all aspects of primary market research, across US market, including project scoping, vendor selection, methodology selection, data collection, analysis and reporting/storytelling. This individual will be an expert in Insight Generation supporting US Brand and broader Commercial team.
Monitor regular brand performance and prepare monthly insights deliverable, performance updates, and ad hoc analyses based on synthesis / analysis of a variety of primary / secondary data sources (e.g., market research, prescribing data, competitive intelligence, field team feedback, customer feedback). Must have excellent knowledge of major US data sources, and ability to drive deep analytics on performance and market dynamics. Must have the ability to manage and prioritize ad-hoc requests with Commercial Leadership Team members
Support and manage monitoring of in-line and pipeline competitors, conducting on-going competitive analyses, threat monitoring, competitive response management, and scenario planning.
5+ years of relevant experience in Life Sciences Consulting (with some execution of market research) or Life Sciences Market Research/Analytics vendor background strongly preferred
Bachelor’s degree required; advanced educational achievement or MBA preferred
Avadel is committed to facilitating an open, honest, inclusive, transparent, and productive work environment where we work together as ONE team and ONE culture to be our best for patients, customers, and each other. Avadel is committed to equal employment opportunity and non-discrimination in employment. We believe that all employees and applicants should be treated with courtesy, dignity, and respect. Avadel does not discriminate in employment on the basis of race, ethnicity, color, religion, sex, sexual orientation, national origin, age, disability status, genetic information, marital status, ancestry, gender, gender identity, pregnancy, veteran status, or any other characteristic protected by federal, state, and/or local law. It is our intent to comply with federal, state, and local laws, regulations, and guidelines in our employment practices and in our service to our clients. This policy applies to all terms and conditions of employment including, but not limited to, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.